Education
About Us
Working with TipRanks
Follow Us
Nancy Valente Insider Profile
4 Followers
Nancy Valente, Director at Myovant Sciences, holds 55.12K shares in Xencor (Ticker: XNCR), holds 0.00 shares in Myovant Sciences (Ticker: MYOV). Most recently, Nancy Valente Sold ― shares of Xencor on May 03, 2024 for an estimated value of 111.84K.
Nancy Valente Myovant Sciences (MYOV)Director
Myovant Sciences (MYOV)
Director
Not Ranked
Nancy Valente has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
EVP, Chief Development Officer
Roles that Nancy Valente holds in companies
Most Profitable Insider Trade
The most profitable trade made by Nancy Valente
Nancy Valente's Trading History
Myovant Sciences
Mar 10, 2023
―
Uninformative Sell
―
$0.00
Xencor
May 03, 2024
EVP, Chief Development Officer
Informative Sell
111.84K
$764.45K
List of latest transactions for each holding click on a transaction to see Nancy Valente's performance on stock
You May Also Like
Nancy Valente insider profile FAQ
What is the percentage of profitable transactions made by Nancy Valente?
The percentage of profitable transactions made by Nancy Valente is ―.
What is the average return per transaction made by Nancy Valente?
The average return per transaction made by Nancy Valente is ―.
What stocks does Nancy Valente hold?
Nancy Valente holds: MYOV, XNCR stocks.
What was Nancy Valente’s latest transaction?
Nancy Valente latest transaction was an Informative Sell of $111.84K.
What was Nancy Valente's most profitable transaction?
Nancy Valente’s most profitable transaction was an Informative Sell of XNCR stock on May 3, 2024. The return on the trade was 42.40%.
What is Nancy Valente's role in Myovant Sciences?
Nancy Valente's role in Myovant Sciences is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.